Filing Details
- Accession Number:
- 0001299130-22-000022
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-17 20:11:42
- Reporting Period:
- 2022-02-16
- Accepted Time:
- 2022-02-17 20:11:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1299130 | Pacific Biosciences Of California Inc. | PACB | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1222643 | Kathy Ordonez | Pacific Biosciences Of California, Inc. 1305 O'Brien Drive Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-02-16 | 3,280 | $11.50 | 18,595 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- This sale price represents the weighted average sale price of the shares sold ranging from $11.50 to $11.505 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Billionaire Hedge Funds
